CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Decoding immune-driven erythroid failure in pure red cell aplasia.
Decoding immune-driven erythroid failure in pure red cell aplasia.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
纯红细胞再生障碍(PRCA)日益被认为是一种T细胞介导的骨髓衰竭综合征,但其免疫遗传学驱动因素仍不明确。Yamashita等人在其论文中整合了人类白细胞抗原(HLA)分型、T细胞受体库分析和突变谱分析,揭示了PRCA患者中富集的HLA等位基因、信号转导和转录激活因子3(STAT3)突变的T细胞克隆以及共享的T细胞受体β(TCRβ)基序。这些发现提示抗原驱动的细胞毒性T细胞反应是红系抑制的核心机制。评论:Yamashita et al. Immunological features of acquired pure red cell aplasia: Specific human leucocyte antigen alleles, signal transducer and activator of transcription 3 mutations and a unique T- cell receptor beta motif. Br J Haematol 2026; 208:1797-1805.
Pure red cell aplasia (PRCA) is increasingly recognised as a T-cell-mediated bone marrow failure syndrome, yet its immunogenetic drivers remain poorly defined. In their paper, Yamashita et al. integrate human leucocyte antigen (HLA) typing, T-cell receptor repertoire analysis and mutational profiling to reveal enriched HLA alleles, signal transducer and activator of transcription 3 (STAT3)-mutated T-cell clones and a shared T cell receptor beta (TCRβ) motif in PRCA patients.
These findings suggest that antigen-driven cytotoxic T-cell responses represent a central mechanism underlying erythroid suppression. Commentary on: Yamashita et al. Immunological features of acquired pure red cell aplasia: Specific human leucocyte antigen alleles, signal transducer and activator of transcription 3 mutations and a unique T- cell receptor beta motif. Br J Haematol 2026; 208:1797-1805.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。